Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Achalasia | Research

Perioperative outcomes of the surgical management of achalasia in two tertiary Cameroonian hospitals: a cohort study

Authors: Joël Igor Kamla, Guy Aristide Bang, Joel Noutakdie Tochie, George Motto Bwelle, Blondel Nana Oumarou, Bernadette Ngo Nonga

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Introduction

Achalasia is a rare esophageal disease with potentially lethal complications. Knowledge of the outcomes of the different surgical treatment modalities for achalasia by Heller’s cardiomyotomy (HCM) helps to choose the safest and most effective option. However, data on the management of achalsia using a Heller myotomy is limited in Africa. Thus, our aim was to determine the perioperative morbidity, mortality and short-term functional outcomes of HCM in Cameroon.

Methodology

We conducted a cohort study throughout a 10-year chart review of patients who underwent HCM for achalasia and were followed up postoperatively for at least three months at two tertiary health centers in Cameroon. We analyzed demographic data, preoperative clinical and imaging data, treatment details, and outcomes at three to twelve months after HCM using the Eckardt score.

Results

We enrolled 29 patients with achalasia having a mean age of 24 ± 16 years and predominantly females (M/F of 1/3.8). The mean symptom duration was 51 ± 20 months. In 80% of cases, the diagnosis was made through a conventional x-ray contrast imaging or “barium swallow test” (93%) and/or an upper gastrointestinal endoscopy (86%). The gold standard diagnostic method via esophageal manometry was unavailable. Preoperatievly, all patients had symptoms suggestive of an active achalasia. HCM was performed via laparotomy in 75% as opposed to 25% laparoscopic HCM procedures. Dor’s anterior partial fundoplication was the main anti-reflux procedure performed (59%). Mucosal perforations were the only intraoperative complications in eight patients (2 during laparoscopy vs. 6 during laparotomy; p > 0.5) and were managed successfully by simple sutures. Postoperative complications were non-severe and occurred in 10% of patients all operated via laparotomy. The mean postoperative length of hospital stay was 7 ± 3 days for laparotomy vs. 5 ± 2 days for laparoscopy; p > 0.5. The perioperative mortality rate was nil. Overall, the short-term postoperative functional outcome was rated excellent; average Eckardt score of 1.5 ± 0.5 (vs. preoperative Eckardt Score of 9 ± 1; p < 0.0001).

Conclusion

Achalasia is diagnosed late in this resource-limited setting. HCM yields satisfactory outcomes, especially via laparoscopic management. An improvement in diagnostic esophageal manometry and mini-invasive surgical infrastructure and the required surgical training/skills are needed for optimal achalasia care.
Literature
1.
go back to reference Leconte M, Douard R, Gaudric M, Dousset B. Traitement Chirurgical Des troubles moteurs de l’œsophage. Journal De Chirurgie. 2008;145(5):428–36.CrossRefPubMed Leconte M, Douard R, Gaudric M, Dousset B. Traitement Chirurgical Des troubles moteurs de l’œsophage. Journal De Chirurgie. 2008;145(5):428–36.CrossRefPubMed
2.
go back to reference Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 2010;22:e256.CrossRefPubMed Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 2010;22:e256.CrossRefPubMed
3.
go back to reference Howard PJ, Maher L, Pryde A, Aameron EW, Heading RC. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut. 1992;33(8):1011–5.CrossRefPubMedPubMedCentral Howard PJ, Maher L, Pryde A, Aameron EW, Heading RC. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut. 1992;33(8):1011–5.CrossRefPubMedPubMedCentral
4.
go back to reference Tebaibia A, Boudjella MA, Boutarene D, Benmediouni F, Brahimi H, Oumnia N. Incidence, clinical features and para-clinical findings of achalasia in Algeria: experience of 25 years. World J Gastroenterol. 2016;22(38):8615–23.CrossRefPubMedPubMedCentral Tebaibia A, Boudjella MA, Boutarene D, Benmediouni F, Brahimi H, Oumnia N. Incidence, clinical features and para-clinical findings of achalasia in Algeria: experience of 25 years. World J Gastroenterol. 2016;22(38):8615–23.CrossRefPubMedPubMedCentral
5.
go back to reference Stein CM, Gelfand M, Taylor HG. Achalasia in Zimbabwean blacks. S Afr Med J. 1985;67(7):261–2.PubMed Stein CM, Gelfand M, Taylor HG. Achalasia in Zimbabwean blacks. S Afr Med J. 1985;67(7):261–2.PubMed
6.
go back to reference Ndjitoyap Ndam EC, Guemne TA, Tzeuton C, Kamdem P, Sosso A, Nguimbous JF, et al. Mégaoesophage idiopathique de l’adulte camerounais: à propos de quatre observations. Méd Afr Noire. 1990;37(8–9):496–8. Ndjitoyap Ndam EC, Guemne TA, Tzeuton C, Kamdem P, Sosso A, Nguimbous JF, et al. Mégaoesophage idiopathique de l’adulte camerounais: à propos de quatre observations. Méd Afr Noire. 1990;37(8–9):496–8.
7.
go back to reference Oumarou BN, Bang GA, Guifo M le, Noah R, Savom DN, Essomba EP. A. Cardiomyotomie De Heller Laparoscopique: À Propos D’un Cas opéré Au Centre Hospitalier d’Essos. Health Sci Disease. 2016;17(3). Oumarou BN, Bang GA, Guifo M le, Noah R, Savom DN, Essomba EP. A. Cardiomyotomie De Heller Laparoscopique: À Propos D’un Cas opéré Au Centre Hospitalier d’Essos. Health Sci Disease. 2016;17(3).
8.
go back to reference Spechler Stuart J, Talley NJ, Robson KM. Achalasia: Pathogenesis, clinical manifestations, and diagnosis. UpToDate, 2021. Spechler Stuart J, Talley NJ, Robson KM. Achalasia: Pathogenesis, clinical manifestations, and diagnosis. UpToDate, 2021.
9.
go back to reference Schlottmann F, Patti M. Esophageal achalasia: current diagnosis and treatment. Expert Rev Gastroenterol Hepatol. 2018;12. Schlottmann F, Patti M. Esophageal achalasia: current diagnosis and treatment. Expert Rev Gastroenterol Hepatol. 2018;12.
10.
go back to reference Leeuwenburgh I, Scholten P, Alderliesten J, Tilanus HW, Looman CWN, Steijerberg EW, et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol. 2010;105(10):2144–9.CrossRefPubMed Leeuwenburgh I, Scholten P, Alderliesten J, Tilanus HW, Looman CWN, Steijerberg EW, et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol. 2010;105(10):2144–9.CrossRefPubMed
11.
go back to reference Lake JM, Wong RK. Review article: the management of achalaisa-a comparison of different modalities. Aliment Pharmacol Ther. 2006;15(6):909–.– 18.Review.CrossRef Lake JM, Wong RK. Review article: the management of achalaisa-a comparison of different modalities. Aliment Pharmacol Ther. 2006;15(6):909–.– 18.Review.CrossRef
12.
go back to reference Spechler Stuart J, Talley NJ, Travis AC. Overview of the treatment of achalasia. UpToDate, 2017. Spechler Stuart J, Talley NJ, Travis AC. Overview of the treatment of achalasia. UpToDate, 2017.
13.
go back to reference Campos GM, Vittinghoff E, Rabl C, Takata M, Gadenstatter M, Lin F, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249(1):45–57.CrossRefPubMed Campos GM, Vittinghoff E, Rabl C, Takata M, Gadenstatter M, Lin F, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249(1):45–57.CrossRefPubMed
14.
go back to reference Torres-Villalobos G, Martin-Del-Campo LA. Surgical treatment for achalasia of the esophagus: Laparoscopic HELLER myotomy. Gastroenterol Res Pract. 2013;2013:5.CrossRef Torres-Villalobos G, Martin-Del-Campo LA. Surgical treatment for achalasia of the esophagus: Laparoscopic HELLER myotomy. Gastroenterol Res Pract. 2013;2013:5.CrossRef
15.
go back to reference Silber W. The prevalence, course and management of some benign oesophageal diseases in the black population. The Groote Schuur Hospital experience. S Afr Med J. 1983;63(25):957–9.PubMed Silber W. The prevalence, course and management of some benign oesophageal diseases in the black population. The Groote Schuur Hospital experience. S Afr Med J. 1983;63(25):957–9.PubMed
16.
go back to reference Razafimahefa S, Rakotondrainibe A et al. Razafitahinjanahary2 C, Rasoaherinomenjanahary F, Rabenjanahary1 T, Rakotovao2 M, Rakotondrainibe A. L’achalasie oesophagienne dans un pays à faibles ressources. Médecine d’Afrique noire. 2012;59:517–22. Razafimahefa S, Rakotondrainibe A et al. Razafitahinjanahary2 C, Rasoaherinomenjanahary F, Rabenjanahary1 T, Rakotovao2 M, Rakotondrainibe A. L’achalasie oesophagienne dans un pays à faibles ressources. Médecine d’Afrique noire. 2012;59:517–22.
17.
go back to reference Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg août. 2009;250(2):187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg août. 2009;250(2):187–96.CrossRef
18.
go back to reference Tebaibia Amar BM, Amine O, Nadia L, Mustapha. Touchene Brahim. Place De La dilatation pneumatique dans la prise en charge de L’achalasie Au cours de la grossesse. JFHOD. 2007. Tebaibia Amar BM, Amine O, Nadia L, Mustapha. Touchene Brahim. Place De La dilatation pneumatique dans la prise en charge de L’achalasie Au cours de la grossesse. JFHOD. 2007.
19.
go back to reference Yaqini K, Béniaz FZ, Mouhaoui M, Moussaoui M, Louardi H. Cas rare de dysphagie révélant une achalasie de l’œsophage. J Marocain Des Sci Médicales. 2014;19(1). Yaqini K, Béniaz FZ, Mouhaoui M, Moussaoui M, Louardi H. Cas rare de dysphagie révélant une achalasie de l’œsophage. J Marocain Des Sci Médicales. 2014;19(1).
20.
go back to reference Eckardt VF, Köhne U, Junginger T. Coll. Risk factors for diagnostic delay in achalasia. Dig Dis Sci. 1997;42:580–5.CrossRefPubMed Eckardt VF, Köhne U, Junginger T. Coll. Risk factors for diagnostic delay in achalasia. Dig Dis Sci. 1997;42:580–5.CrossRefPubMed
21.
go back to reference Taft TH, Carlson DA, Triggs J, Craft J, Starkey K, Yadlapati R, et al. Evaluating the reliability and construct validity of the Eckardt Symptom Score as a measure of Achalasia Severity. Neurogastroenterol Motil. 2018;30(6):e13287.CrossRefPubMedPubMedCentral Taft TH, Carlson DA, Triggs J, Craft J, Starkey K, Yadlapati R, et al. Evaluating the reliability and construct validity of the Eckardt Symptom Score as a measure of Achalasia Severity. Neurogastroenterol Motil. 2018;30(6):e13287.CrossRefPubMedPubMedCentral
22.
go back to reference Carlson DA, Pandolfino JE. High-resolution manometry and esophageal pressure topography: filling the gaps of convention manometry. Gastroenterol Clin North Am. 2013;42(1):1–15.CrossRefPubMed Carlson DA, Pandolfino JE. High-resolution manometry and esophageal pressure topography: filling the gaps of convention manometry. Gastroenterol Clin North Am. 2013;42(1):1–15.CrossRefPubMed
Metadata
Title
Perioperative outcomes of the surgical management of achalasia in two tertiary Cameroonian hospitals: a cohort study
Authors
Joël Igor Kamla
Guy Aristide Bang
Joel Noutakdie Tochie
George Motto Bwelle
Blondel Nana Oumarou
Bernadette Ngo Nonga
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03191-1

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.